JP2004520424A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004520424A5 JP2004520424A5 JP2002569807A JP2002569807A JP2004520424A5 JP 2004520424 A5 JP2004520424 A5 JP 2004520424A5 JP 2002569807 A JP2002569807 A JP 2002569807A JP 2002569807 A JP2002569807 A JP 2002569807A JP 2004520424 A5 JP2004520424 A5 JP 2004520424A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- oxo
- chlorobenzyl
- ylmethyl
- dihydroquinoline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 150000001875 compounds Chemical class 0.000 claims 22
- -1 morpholinylmethyl Chemical group 0.000 claims 15
- 125000000217 alkyl group Chemical group 0.000 claims 9
- 239000008194 pharmaceutical composition Substances 0.000 claims 9
- 125000006283 4-chlorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1Cl)C([H])([H])* 0.000 claims 7
- 229910052799 carbon Inorganic materials 0.000 claims 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims 6
- 241000124008 Mammalia Species 0.000 claims 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 5
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims 4
- MGWPYFURPLZGBR-UHFFFAOYSA-N n-[(4-chlorophenyl)methyl]-8-(4-hydroxybut-1-ynyl)-1-methyl-6-(morpholin-4-ylmethyl)-4-oxoquinoline-3-carboxamide Chemical compound O=C1C2=CC(CN3CCOCC3)=CC(C#CCCO)=C2N(C)C=C1C(=O)NCC1=CC=C(Cl)C=C1 MGWPYFURPLZGBR-UHFFFAOYSA-N 0.000 claims 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 4
- 241001529453 unidentified herpesvirus Species 0.000 claims 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical group N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 claims 3
- 125000005843 halogen group Chemical group 0.000 claims 3
- 229910052739 hydrogen Inorganic materials 0.000 claims 3
- VCVYCVVYIFPQEG-UHFFFAOYSA-N n-[(4-chlorophenyl)methyl]-8-(3-hydroxyprop-1-ynyl)-1-methyl-6-(oxan-4-ylmethyl)-4-oxoquinoline-3-carboxamide Chemical compound O=C1C2=CC(CC3CCOCC3)=CC(C#CCO)=C2N(C)C=C1C(=O)NCC1=CC=C(Cl)C=C1 VCVYCVVYIFPQEG-UHFFFAOYSA-N 0.000 claims 3
- LIMCXBXZXQIZJC-UHFFFAOYSA-N n-[(4-chlorophenyl)methyl]-8-(4-hydroxybut-1-ynyl)-1-methyl-6-(oxan-4-ylmethyl)-4-oxoquinoline-3-carboxamide Chemical compound O=C1C2=CC(CC3CCOCC3)=CC(C#CCCO)=C2N(C)C=C1C(=O)NCC1=CC=C(Cl)C=C1 LIMCXBXZXQIZJC-UHFFFAOYSA-N 0.000 claims 3
- GFIYDHXQIDHBOG-GOSISDBHSA-N n-[(4-chlorophenyl)methyl]-8-[(3r)-3-hydroxybut-1-ynyl]-1-methyl-6-(morpholin-4-ylmethyl)-4-oxoquinoline-3-carboxamide Chemical compound C=1C(C(C(C(=O)NCC=2C=CC(Cl)=CC=2)=CN2C)=O)=C2C(C#C[C@H](O)C)=CC=1CN1CCOCC1 GFIYDHXQIDHBOG-GOSISDBHSA-N 0.000 claims 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 3
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 2
- CVAWACBLSANHSQ-UHFFFAOYSA-N 4-oxo-1h-quinoline-3-carboxamide Chemical compound C1=CC=CC2=C(O)C(C(=O)N)=CN=C21 CVAWACBLSANHSQ-UHFFFAOYSA-N 0.000 claims 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims 2
- 241000282414 Homo sapiens Species 0.000 claims 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 claims 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 claims 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims 2
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 claims 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 2
- 108020005202 Viral DNA Proteins 0.000 claims 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 2
- 230000037396 body weight Effects 0.000 claims 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 2
- 125000005842 heteroatom Chemical group 0.000 claims 2
- 125000000623 heterocyclic group Chemical group 0.000 claims 2
- 230000002401 inhibitory effect Effects 0.000 claims 2
- FHWSUYOPVRGYSQ-UHFFFAOYSA-N n-[(4-chlorophenyl)methyl]-1-methyl-6-(morpholin-4-ylmethyl)-4-oxo-8-(2-pyridin-2-ylethynyl)quinoline-3-carboxamide Chemical compound O=C1C2=CC(CN3CCOCC3)=CC(C#CC=3N=CC=CC=3)=C2N(C)C=C1C(=O)NCC1=CC=C(Cl)C=C1 FHWSUYOPVRGYSQ-UHFFFAOYSA-N 0.000 claims 2
- OPJOHUGGAJPPFT-UHFFFAOYSA-N n-[(4-chlorophenyl)methyl]-1-methyl-6-(morpholin-4-ylmethyl)-4-oxo-8-(2-pyridin-3-ylethynyl)quinoline-3-carboxamide Chemical compound O=C1C2=CC(CN3CCOCC3)=CC(C#CC=3C=NC=CC=3)=C2N(C)C=C1C(=O)NCC1=CC=C(Cl)C=C1 OPJOHUGGAJPPFT-UHFFFAOYSA-N 0.000 claims 2
- NYQSBTHWIBQUKL-UHFFFAOYSA-N n-[(4-chlorophenyl)methyl]-1-methyl-6-(morpholin-4-ylmethyl)-4-oxo-8-(2-pyridin-4-ylethynyl)quinoline-3-carboxamide Chemical compound O=C1C2=CC(CN3CCOCC3)=CC(C#CC=3C=CN=CC=3)=C2N(C)C=C1C(=O)NCC1=CC=C(Cl)C=C1 NYQSBTHWIBQUKL-UHFFFAOYSA-N 0.000 claims 2
- PKTJQQZTTYHRPO-XMMPIXPASA-N n-[(4-chlorophenyl)methyl]-1-methyl-6-(morpholin-4-ylmethyl)-4-oxo-8-[4-[(4r)-2-oxo-1,3-oxazolidin-4-yl]but-1-ynyl]quinoline-3-carboxamide Chemical compound O=C1C2=CC(CN3CCOCC3)=CC(C#CCC[C@H]3NC(=O)OC3)=C2N(C)C=C1C(=O)NCC1=CC=C(Cl)C=C1 PKTJQQZTTYHRPO-XMMPIXPASA-N 0.000 claims 2
- SBFDYTBWVDUUFQ-UHFFFAOYSA-N n-[(4-chlorophenyl)methyl]-1-methyl-8-[3-(5-methylimidazol-1-yl)prop-1-ynyl]-6-(morpholin-4-ylmethyl)-4-oxoquinoline-3-carboxamide Chemical compound CC1=CN=CN1CC#CC1=CC(CN2CCOCC2)=CC(C2=O)=C1N(C)C=C2C(=O)NCC1=CC=C(Cl)C=C1 SBFDYTBWVDUUFQ-UHFFFAOYSA-N 0.000 claims 2
- AHTWPTOJRMBDCN-UHFFFAOYSA-N n-[(4-chlorophenyl)methyl]-8-(3-fluoroprop-1-ynyl)-1-methyl-6-(morpholin-4-ylmethyl)-4-oxoquinoline-3-carboxamide Chemical compound O=C1C2=CC(CN3CCOCC3)=CC(C#CCF)=C2N(C)C=C1C(=O)NCC1=CC=C(Cl)C=C1 AHTWPTOJRMBDCN-UHFFFAOYSA-N 0.000 claims 2
- VSWHIJKJQVVFJA-UHFFFAOYSA-N n-[(4-chlorophenyl)methyl]-8-(3-hydroxyprop-1-ynyl)-1-methyl-6-(morpholin-4-ylmethyl)-4-oxoquinoline-3-carboxamide Chemical compound O=C1C2=CC(CN3CCOCC3)=CC(C#CCO)=C2N(C)C=C1C(=O)NCC1=CC=C(Cl)C=C1 VSWHIJKJQVVFJA-UHFFFAOYSA-N 0.000 claims 2
- UDGHVURPBHORHE-UHFFFAOYSA-N n-[(4-chlorophenyl)methyl]-8-(3-imidazol-1-ylprop-1-ynyl)-1-methyl-6-(morpholin-4-ylmethyl)-4-oxoquinoline-3-carboxamide Chemical compound O=C1C2=CC(CN3CCOCC3)=CC(C#CCN3C=NC=C3)=C2N(C)C=C1C(=O)NCC1=CC=C(Cl)C=C1 UDGHVURPBHORHE-UHFFFAOYSA-N 0.000 claims 2
- FNALQGUDHPRRGW-UHFFFAOYSA-N n-[(4-chlorophenyl)methyl]-8-(5-hydroxypent-1-ynyl)-1-methyl-6-(morpholin-4-ylmethyl)-4-oxoquinoline-3-carboxamide Chemical compound O=C1C2=CC(CN3CCOCC3)=CC(C#CCCCO)=C2N(C)C=C1C(=O)NCC1=CC=C(Cl)C=C1 FNALQGUDHPRRGW-UHFFFAOYSA-N 0.000 claims 2
- GFIYDHXQIDHBOG-SFHVURJKSA-N n-[(4-chlorophenyl)methyl]-8-[(3s)-3-hydroxybut-1-ynyl]-1-methyl-6-(morpholin-4-ylmethyl)-4-oxoquinoline-3-carboxamide Chemical compound C=1C(C(C(C(=O)NCC=2C=CC(Cl)=CC=2)=CN2C)=O)=C2C(C#C[C@@H](O)C)=CC=1CN1CCOCC1 GFIYDHXQIDHBOG-SFHVURJKSA-N 0.000 claims 2
- KVWPVZONWRAHLF-UHFFFAOYSA-N n-[(4-chlorophenyl)methyl]-8-[3-(3-hydroxypyrrolidin-1-yl)prop-1-ynyl]-1-methyl-6-(morpholin-4-ylmethyl)-4-oxoquinoline-3-carboxamide Chemical compound O=C1C2=CC(CN3CCOCC3)=CC(C#CCN3CC(O)CC3)=C2N(C)C=C1C(=O)NCC1=CC=C(Cl)C=C1 KVWPVZONWRAHLF-UHFFFAOYSA-N 0.000 claims 2
- ZRGCVFFOPWYAGJ-UHFFFAOYSA-N n-[(4-chlorophenyl)methyl]-8-[3-(4,5-dichloroimidazol-1-yl)prop-1-ynyl]-1-methyl-6-(morpholin-4-ylmethyl)-4-oxoquinoline-3-carboxamide Chemical compound O=C1C2=CC(CN3CCOCC3)=CC(C#CCN3C(=C(Cl)N=C3)Cl)=C2N(C)C=C1C(=O)NCC1=CC=C(Cl)C=C1 ZRGCVFFOPWYAGJ-UHFFFAOYSA-N 0.000 claims 2
- SMOWTBSZIOTETF-UHFFFAOYSA-N n-[(4-chlorophenyl)methyl]-8-[3-(dimethylamino)prop-1-ynyl]-1-methyl-6-(morpholin-4-ylmethyl)-4-oxoquinoline-3-carboxamide Chemical compound C=1C(C(C(C(=O)NCC=2C=CC(Cl)=CC=2)=CN2C)=O)=C2C(C#CCN(C)C)=CC=1CN1CCOCC1 SMOWTBSZIOTETF-UHFFFAOYSA-N 0.000 claims 2
- XZQYPQNRUZEBDT-UHFFFAOYSA-N n-[(4-chlorophenyl)methyl]-8-[3-(dimethylamino)prop-1-ynyl]-1-methyl-6-(oxan-4-ylmethyl)-4-oxoquinoline-3-carboxamide Chemical compound C=1C(C(C(C(=O)NCC=2C=CC(Cl)=CC=2)=CN2C)=O)=C2C(C#CCN(C)C)=CC=1CC1CCOCC1 XZQYPQNRUZEBDT-UHFFFAOYSA-N 0.000 claims 2
- OVZQONYEPMLPOM-AREMUKBSSA-N n-[(4-chlorophenyl)methyl]-8-[3-[(2r)-2-(hydroxymethyl)pyrrolidin-1-yl]prop-1-ynyl]-1-methyl-6-(morpholin-4-ylmethyl)-4-oxoquinoline-3-carboxamide Chemical compound O=C1C2=CC(CN3CCOCC3)=CC(C#CCN3[C@H](CCC3)CO)=C2N(C)C=C1C(=O)NCC1=CC=C(Cl)C=C1 OVZQONYEPMLPOM-AREMUKBSSA-N 0.000 claims 2
- QYGAFRCYZAFZAH-UHFFFAOYSA-N n-[(4-chlorophenyl)methyl]-8-[3-[2-(2-hydroxyethyl)piperidin-1-yl]prop-1-ynyl]-1-methyl-6-(morpholin-4-ylmethyl)-4-oxoquinoline-3-carboxamide Chemical compound O=C1C2=CC(CN3CCOCC3)=CC(C#CCN3C(CCCC3)CCO)=C2N(C)C=C1C(=O)NCC1=CC=C(Cl)C=C1 QYGAFRCYZAFZAH-UHFFFAOYSA-N 0.000 claims 2
- UPTHOHQEWDJKIE-UHFFFAOYSA-N n-[(4-chlorophenyl)methyl]-8-[3-[4-(2-hydroxyethyl)piperazin-1-yl]prop-1-ynyl]-1-methyl-6-(morpholin-4-ylmethyl)-4-oxoquinoline-3-carboxamide Chemical compound O=C1C2=CC(CN3CCOCC3)=CC(C#CCN3CCN(CCO)CC3)=C2N(C)C=C1C(=O)NCC1=CC=C(Cl)C=C1 UPTHOHQEWDJKIE-UHFFFAOYSA-N 0.000 claims 2
- QOZAPTVTTIRFKC-UHFFFAOYSA-N n-[(4-chlorophenyl)methyl]-8-[5-hydroxy-4-(hydroxymethyl)pent-1-ynyl]-1-methyl-6-(morpholin-4-ylmethyl)-4-oxoquinoline-3-carboxamide Chemical compound O=C1C2=CC(CN3CCOCC3)=CC(C#CCC(CO)CO)=C2N(C)C=C1C(=O)NCC1=CC=C(Cl)C=C1 QOZAPTVTTIRFKC-UHFFFAOYSA-N 0.000 claims 2
- 229910052757 nitrogen Chemical group 0.000 claims 2
- 229910052760 oxygen Inorganic materials 0.000 claims 2
- 239000001301 oxygen Substances 0.000 claims 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 229920006395 saturated elastomer Polymers 0.000 claims 2
- 125000001424 substituent group Chemical group 0.000 claims 2
- 229910052717 sulfur Inorganic materials 0.000 claims 2
- 239000011593 sulfur Chemical group 0.000 claims 2
- 125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 claims 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 claims 1
- MKITVSKAOUHTMH-LJQANCHMSA-N C=1C(C(C(C(=O)NCC=2C=CC(Cl)=CC=2)=CN2C)=O)=C2C(C#CC[C@H](O)C)=CC=1CN1CCOCC1 Chemical compound C=1C(C(C(C(=O)NCC=2C=CC(Cl)=CC=2)=CN2C)=O)=C2C(C#CC[C@H](O)C)=CC=1CN1CCOCC1 MKITVSKAOUHTMH-LJQANCHMSA-N 0.000 claims 1
- 241000701022 Cytomegalovirus Species 0.000 claims 1
- 208000029433 Herpesviridae infectious disease Diseases 0.000 claims 1
- 241000700588 Human alphaherpesvirus 1 Species 0.000 claims 1
- 241000701074 Human alphaherpesvirus 2 Species 0.000 claims 1
- 241000701085 Human alphaherpesvirus 3 Species 0.000 claims 1
- 241000701024 Human betaherpesvirus 5 Species 0.000 claims 1
- 241000701041 Human betaherpesvirus 7 Species 0.000 claims 1
- 241000701044 Human gammaherpesvirus 4 Species 0.000 claims 1
- 241000701027 Human herpesvirus 6 Species 0.000 claims 1
- 241001465754 Metazoa Species 0.000 claims 1
- ZBAWVIILDZKQQK-DEOSSOPVSA-N O=C1C2=CC(CN3CCOCC3)=CC(C#CCN3C[C@@H](CO)CCC3)=C2N(C)C=C1C(=O)NCC1=CC=C(Cl)C=C1 Chemical compound O=C1C2=CC(CN3CCOCC3)=CC(C#CCN3C[C@@H](CO)CCC3)=C2N(C)C=C1C(=O)NCC1=CC=C(Cl)C=C1 ZBAWVIILDZKQQK-DEOSSOPVSA-N 0.000 claims 1
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 claims 1
- WYNCHZVNFNFDNH-UHFFFAOYSA-N Oxazolidine Chemical compound C1COCN1 WYNCHZVNFNFDNH-UHFFFAOYSA-N 0.000 claims 1
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 claims 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 claims 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 claims 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 claims 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- MKITVSKAOUHTMH-UHFFFAOYSA-N n-[(4-chlorophenyl)methyl]-8-(4-hydroxypent-1-ynyl)-1-methyl-6-(morpholin-4-ylmethyl)-4-oxoquinoline-3-carboxamide Chemical compound C=1C(C(C(C(=O)NCC=2C=CC(Cl)=CC=2)=CN2C)=O)=C2C(C#CCC(O)C)=CC=1CN1CCOCC1 MKITVSKAOUHTMH-UHFFFAOYSA-N 0.000 claims 1
- SXQAGZQPQZBYCI-UHFFFAOYSA-N n-[(4-chlorophenyl)methyl]-8-[3-(3-hydroxypiperidin-1-yl)prop-1-ynyl]-1-methyl-6-(morpholin-4-ylmethyl)-4-oxoquinoline-3-carboxamide Chemical compound O=C1C2=CC(CN3CCOCC3)=CC(C#CCN3CC(O)CCC3)=C2N(C)C=C1C(=O)NCC1=CC=C(Cl)C=C1 SXQAGZQPQZBYCI-UHFFFAOYSA-N 0.000 claims 1
- ZOGKFJZEKLAULV-UHFFFAOYSA-N n-[(4-chlorophenyl)methyl]-8-[3-(4-hydroxypiperidin-1-yl)prop-1-ynyl]-1-methyl-6-(morpholin-4-ylmethyl)-4-oxoquinoline-3-carboxamide Chemical compound O=C1C2=CC(CN3CCOCC3)=CC(C#CCN3CCC(O)CC3)=C2N(C)C=C1C(=O)NCC1=CC=C(Cl)C=C1 ZOGKFJZEKLAULV-UHFFFAOYSA-N 0.000 claims 1
- OVZQONYEPMLPOM-SANMLTNESA-N n-[(4-chlorophenyl)methyl]-8-[3-[(2s)-2-(hydroxymethyl)pyrrolidin-1-yl]prop-1-ynyl]-1-methyl-6-(morpholin-4-ylmethyl)-4-oxoquinoline-3-carboxamide Chemical compound O=C1C2=CC(CN3CCOCC3)=CC(C#CCN3[C@@H](CCC3)CO)=C2N(C)C=C1C(=O)NCC1=CC=C(Cl)C=C1 OVZQONYEPMLPOM-SANMLTNESA-N 0.000 claims 1
- UIYLHDWLEFCUHE-UHFFFAOYSA-N n-[(4-chlorophenyl)methyl]-8-[3-[2-hydroxyethyl(methyl)amino]prop-1-ynyl]-1-methyl-6-(morpholin-4-ylmethyl)-4-oxoquinoline-3-carboxamide Chemical compound C=1C(C(C(C(=O)NCC=2C=CC(Cl)=CC=2)=CN2C)=O)=C2C(C#CCN(CCO)C)=CC=1CN1CCOCC1 UIYLHDWLEFCUHE-UHFFFAOYSA-N 0.000 claims 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 1
- WCPAKWJPBJAGKN-UHFFFAOYSA-N oxadiazole Chemical compound C1=CON=N1 WCPAKWJPBJAGKN-UHFFFAOYSA-N 0.000 claims 1
- 150000002923 oximes Chemical class 0.000 claims 1
- 238000007911 parenteral administration Methods 0.000 claims 1
- VLLMWSRANPNYQX-UHFFFAOYSA-N thiadiazole Chemical compound C1=CSN=N1.C1=CSN=N1 VLLMWSRANPNYQX-UHFFFAOYSA-N 0.000 claims 1
- BRNULMACUQOKMR-UHFFFAOYSA-N thiomorpholine Chemical compound C1CSCCN1 BRNULMACUQOKMR-UHFFFAOYSA-N 0.000 claims 1
- 238000011200 topical administration Methods 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27260701P | 2001-03-01 | 2001-03-01 | |
| PCT/US2002/003407 WO2002070487A1 (en) | 2001-03-01 | 2002-02-27 | Substituted quinolinecarboxamides as antiviral agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004520424A JP2004520424A (ja) | 2004-07-08 |
| JP2004520424A5 true JP2004520424A5 (enExample) | 2005-12-22 |
Family
ID=23040509
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002569807A Withdrawn JP2004520424A (ja) | 2001-03-01 | 2002-02-27 | 抗ウイルス剤としての置換型キノリンカルボキサミド |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US6544990B2 (enExample) |
| EP (1) | EP1363887A1 (enExample) |
| JP (1) | JP2004520424A (enExample) |
| CA (1) | CA2433467A1 (enExample) |
| PE (1) | PE20020974A1 (enExample) |
| WO (1) | WO2002070487A1 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002070487A1 (en) * | 2001-03-01 | 2002-09-12 | Pharmacia & Upjohn Company | Substituted quinolinecarboxamides as antiviral agents |
| AU2003262947A1 (en) * | 2002-08-30 | 2004-03-19 | Pharmacia And Upjohn Company | Method of preventing or treating atherosclerosis or restenosis |
| US20040176366A1 (en) * | 2002-08-30 | 2004-09-09 | Wathen Michael W | Method of preventing or treating atherosclerosis or restenosis |
| WO2005009971A1 (ja) | 2003-07-24 | 2005-02-03 | Astellas Pharma Inc. | キノロン誘導体又はその塩 |
| CN100532362C (zh) * | 2004-04-13 | 2009-08-26 | 中国科学院化学研究所 | 酯类反应性溶剂制备碘化n-甲基喹啉类化合物的方法 |
| MY189505A (en) | 2012-10-16 | 2022-02-16 | Janssen Pharmaceutica Nv | Methylene linked quinolinyl modulators of roryt |
| HK1213887A1 (zh) | 2012-10-16 | 2016-07-15 | Janssen Pharmaceutica N.V. | RORγt的苯基连接的喹啉基调节剂 |
| WO2014062655A1 (en) | 2012-10-16 | 2014-04-24 | Janssen Pharmaceutica Nv | HETEROARYL LINKED QUINOLINYL MODULATORS OF RORyt |
| WO2014070976A1 (en) * | 2012-11-03 | 2014-05-08 | Boehringer Ingelheim International Gmbh | Inhibitors of cytomegalovirus |
| US9403816B2 (en) | 2013-10-15 | 2016-08-02 | Janssen Pharmaceutica Nv | Phenyl linked quinolinyl modulators of RORγt |
| CA2927182A1 (en) | 2013-10-15 | 2015-04-23 | Janssen Pharmaceutica Nv | Quinolinyl modulators of ror.gamma.t |
| US9328095B2 (en) | 2013-10-15 | 2016-05-03 | Janssen Pharmaceutica Nv | Heteroaryl linked quinolinyl modulators of RORgammat |
| US9284308B2 (en) | 2013-10-15 | 2016-03-15 | Janssen Pharmaceutica Nv | Methylene linked quinolinyl modulators of RORγt |
| US9221804B2 (en) | 2013-10-15 | 2015-12-29 | Janssen Pharmaceutica Nv | Secondary alcohol quinolinyl modulators of RORγt |
| US10555941B2 (en) | 2013-10-15 | 2020-02-11 | Janssen Pharmaceutica Nv | Alkyl linked quinolinyl modulators of RORγt |
| CA2926339A1 (en) | 2013-10-15 | 2015-04-23 | Janssen Pharmaceutica Nv | Alkyl linked quinolinyl modulators of roryt |
| US11072610B2 (en) | 2018-09-12 | 2021-07-27 | Novartis Ag | Antiviral pyridopyrazinedione compounds |
| CN114667285B (zh) | 2019-09-26 | 2025-08-08 | 诺华股份有限公司 | 抗病毒吡唑并吡啶酮化合物 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT841929E (pt) | 1995-08-02 | 2003-09-30 | Darwin Discovery Ltd | Quinolonas e sua utilizacao terapeutica |
| EP1042295B1 (en) | 1997-12-22 | 2005-09-07 | Pharmacia & Upjohn Company LLC | 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents |
| US6248736B1 (en) * | 1999-01-08 | 2001-06-19 | Pharmacia & Upjohn Company | 4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents |
| US6248739B1 (en) * | 1999-01-08 | 2001-06-19 | Pharmacia & Upjohn Company | Quinolinecarboxamides as antiviral agents |
| US6682892B2 (en) * | 2000-07-13 | 2004-01-27 | Pharmacia & Upjohn Company | Method for treating herpes viruses |
| WO2002070487A1 (en) * | 2001-03-01 | 2002-09-12 | Pharmacia & Upjohn Company | Substituted quinolinecarboxamides as antiviral agents |
-
2002
- 2002-02-27 WO PCT/US2002/003407 patent/WO2002070487A1/en not_active Ceased
- 2002-02-27 JP JP2002569807A patent/JP2004520424A/ja not_active Withdrawn
- 2002-02-27 US US10/084,015 patent/US6544990B2/en not_active Expired - Fee Related
- 2002-02-27 EP EP02709361A patent/EP1363887A1/en not_active Withdrawn
- 2002-02-27 CA CA002433467A patent/CA2433467A1/en not_active Abandoned
- 2002-02-28 PE PE2002000167A patent/PE20020974A1/es not_active Application Discontinuation
-
2003
- 2003-01-23 US US10/350,248 patent/US6727248B2/en not_active Expired - Fee Related